Privé, Bastiaan M. http://orcid.org/0000-0002-4056-9117
Janssen, Marcel J. R.
van Oort, Inge M.
Muselaers, Constantijn H. J.
Jonker, Marianne A.
van Gemert, Willemijn A.
de Groot, Michel
Westdorp, Harm
Mehra, Niven
Verzijlbergen, J. Fred
Scheenen, Tom W. J.
Zámecnik, Patrik
Barentsz, Jelle O.
Gotthardt, Martin
Noordzij, Walter
Vogel, Wouter V.
Bergman, Andries M.
van der Poel, Henk G.
Vis, André N.
Oprea-Lager, Daniela E.
Gerritsen, Winald R.
Witjes, J. Alfred
Nagarajah, James
Funding for this research was provided by:
Prostaatkankerstichting
Advanced Accelerator Applications, a Novartis Company
Article History
Received: 24 August 2021
Accepted: 19 October 2021
First Online: 4 November 2021
Declarations
:
: The study protocol and the following amendments were approved by the Medical Review Ethics Committee Arnhem-Nijmegen, The Netherlands. All study participants will provide informed consent before study entry.
: Not applicable.
: JN receives research support from ABX Pharmaceuticals and Advanced Accelerator Applications.